Revenue
2012
2013
2014
2015
2016
2021
2022
2023
2024
2025
Processa Pharmaceuticals, Inc. (PCSA)
Price$2.06Cached quote
Net income
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2012
2013
2014
2015
2016
2017
2018
2023
2024
2025
Total cash / debt
CashTotal debt
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | — | — | — | — | $5,000 | $113,425 | $107,239 | $312,480 | $192,145 |
| Gross profit | — | — | — | — | — | — | — | — | — | $5,000 | −$12,451 | $40,406 | $124,478 | $58,890 |
| Gross margin | — | — | — | — | — | — | — | — | — | 100.00% | −10.98% | 37.68% | 39.84% | 30.65% |
| Research & development | $7.8M | $7.3M | $5.8M | $11.5M | $6.9M | $3.2M | $2.3M | $3.1M | $964,164 | $1.5M | $29,246 | $178,085 | $267,062 | $448,028 |
| Operating expenses | $14.0M | $12.1M | $11.5M | $20.3M | — | — | — | — | $1.8M | $1.9M | $2.7M | $3.4M | $3.1M | $2.3M |
| Operating income | −$14.0M | −$12.1M | −$11.5M | −$27.5M | −$12.1M | −$15.1M | −$3.9M | −$4.5M | −$1.8M | −$1.9M | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | −38,430.40% | — | — | — | — |
| EBITDA | −$14.0M | −$12.1M | −$11.5M | −$19.5M | −$11.3M | −$14.3M | −$3.1M | −$3.9M | −$1.8M | −$1.9M | — | — | — | — |
| EBITDA margin | — | — | — | — | — | — | — | — | — | −38,402.78% | — | — | — | — |
| Net income | −$13.6M | −$11.9M | −$11.1M | −$27.4M | −$11.4M | −$14.4M | −$3.4M | −$3.8M | −$1.9M | −$1.9M | −$3.4M | −$4.5M | −$3.1M | −$2.4M |
| Net profit margin | — | — | — | — | — | — | — | — | — | −38,341.32% | −2,957.22% | −4,220.71% | −982.05% | −1,270.15% |
| Basic EPSper basic share | -$10.36 | -$96.78 | -$212.00 | -$851.25 | -$375.00 | -$1,270.00 | -$350.00 | -$355.00 | -$210.00 | -$245.00 | -$1,085.00 | -$2,380.00 | -$2,135.00 | -$5,250.00 |
| Diluted EPSper diluted share | -$10.36 | -$96.78 | -$212.00 | -$851.25 | -$375.00 | -$1,270.00 | -$350.00 | -$355.00 | -$210.00 | -$245.00 | -$1,085.00 | -$2,380.00 | -$2,135.00 | -$5,250.00 |
Owners
Reported shareholders
3.05%of listed shares
Connective Capital Management, LLC85.27K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Connective Capital Management, LLC | 3.05%85.27K shares |
Stonepine Capital Management, LLC | 1.97%55K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.79%22.09K shares |
Young David | ≈0.78%21.88K shares |
CITADEL ADVISORS LLC | 0.76%21.31K shares |
Ng George K | ≈0.60%16.72K shares |
SKIBSTED RUSSELL | ≈0.48%13.41K shares |
XTX Topco Ltd | 0.48%13.29K shares |
JANE STREET GROUP, LLC | 0.47%13.26K shares |
Lin Patrick | ≈0.46%12.75K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.46%12.73K shares |
Guy Wendy | ≈0.44%12.29K shares |
StoneX Group Inc. | 0.41%11.44K shares |
VANGUARD FIDUCIARY TRUST CO | 0.39%10.86K shares |
UBS Group AG | 0.28%7.79K shares |
Bigora Sian | ≈0.28%7.75K shares |
Stanker James H | ≈0.23%6.48K shares |
Baluch Khoso | ≈0.09%2.53K shares |
Tower Research Capital LLC (TRC) | 0.09%2.5K shares |
Pannu Geraldine | ≈0.09%2.39K shares |
Percentages use 2.79M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026Form 4 | Young DavidPres. Research & Development | BuyCommon Stock | 2.1K | $2.22 | $4.6K | 19.2K |
| Jun 15, 2026Form 4 | SKIBSTED RUSSELLChief Financial Officer | BuyCommon Stock | 2.7K | $2.22 | $5.9K | 13.4K |
| Jun 15, 2026Form 4 | Ng George KChief Executive Officer | BuyCommon Stock | 2.5K | $2.22 | $5.5K | 12.4K |
| Jun 15, 2026Form 4 | Lin PatrickChief Business - Strategy Off | BuyCommon Stock | 1.8K | $2.22 | $4.1K | 11.0K |
| Jun 15, 2026Form 4 | Guy WendyChief Administrative Officer | BuyCommon Stock | 2.1K | $2.22 | $4.7K | 12.0K |